CCL22 Human 1-chloro-2,4-dinitrobenzene affects expression ISO Ccl22 (Mus musculus) 6480464 Dinitrochlorobenzene affects the expression of CCL22 mRNA CTD PMID:28219650 CCL22 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ccl22 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CCL22 mRNA CTD PMID:21570461 and PMID:26377647 CCL22 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ccl22 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCL22 mRNA CTD PMID:21509788 CCL22 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ccl22 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 CCL22 Human 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL22 mRNA] CTD PMID:17109745 CCL22 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CCL22 mRNA CTD PMID:30851411 CCL22 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Ccl22 (Rattus norvegicus) 6480464 3 more ... CTD PMID:32119087 CCL22 Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [AHR gene mutant form affects the susceptibility to 3 more ... CTD PMID:34256052 CCL22 Human 3-phenylprop-2-enal decreases expression ISO Ccl22 (Mus musculus) 6480464 cinnamaldehyde results in decreased expression of CCL22 mRNA CTD PMID:28219650 CCL22 Human 4-hydroxynon-2-enal decreases expression ISO Ccl22 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of CCL22 mRNA CTD PMID:19191707 CCL22 Human 6-propyl-2-thiouracil decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of CCL22 mRNA CTD PMID:24780913 CCL22 Human acetohydrazide decreases expression ISO Ccl22 (Mus musculus) 6480464 acetylhydrazine results in decreased expression of CCL22 mRNA CTD PMID:15282401 CCL22 Human aldehydo-D-glucosamine multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL22 mRNA] CTD PMID:17109745 CCL22 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CCL22 mRNA and Tretinoin results in increased expression of CCL22 protein CTD PMID:19828696 and PMID:33167477 CCL22 Human all-trans-retinoic acid multiple interactions EXP 6480464 [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA CTD PMID:19828696 CCL22 Human allopurinol multiple interactions EXP 6480464 Allopurinol inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased secretion of CCL22 protein] and Allopurinol inhibits the reaction [TNF protein results in increased expression of CCL22 mRNA] CTD PMID:28949055 CCL22 Human alloxanthine multiple interactions EXP 6480464 Oxypurinol inhibits the reaction [TNF protein results in increased expression of CCL22 mRNA] CTD PMID:28949055 CCL22 Human alpha-Zearalanol increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Zeranol results in increased expression of CCL22 mRNA CTD PMID:35163327 CCL22 Human ammonium chloride affects expression ISO Ccl22 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CCL22 mRNA CTD PMID:16483693 CCL22 Human aripiprazole multiple interactions EXP 6480464 Aripiprazole inhibits the reaction [Ozone results in increased expression of CCL22 mRNA] CTD PMID:31476115 CCL22 Human Aroclor 1254 multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1242 co-treated with aroclor 1248] results in increased expression of CCL22 mRNA CTD PMID:29879404 CCL22 Human arsane decreases response to substance EXP 6480464 CCL22 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 CCL22 Human arsenic atom decreases response to substance EXP 6480464 CCL22 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 CCL22 Human arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL22 mRNA] CTD PMID:19350554 and PMID:19828696 CCL22 Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CCL22 mRNA CTD PMID:19128835 and PMID:19350554 CCL22 Human Bandrowski's base affects expression EXP 6480464 Bandrowski's base affects the expression of CCL22 mRNA CTD PMID:18202158 CCL22 Human barium sulfate increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Barium Sulfate results in increased expression of CCL22 mRNA CTD PMID:29463257 CCL22 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CCL22 promoter CTD PMID:27901495 CCL22 Human benzo[a]pyrene decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of CCL22 protein CTD PMID:35378083 CCL22 Human benzo[a]pyrene multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of CCL22 protein] and Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of CCL22 protein] CTD PMID:35378083 CCL22 Human beta-D-glucosamine multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CCL22 mRNA] CTD PMID:17109745 CCL22 Human beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CCL22 mRNA CTD PMID:32858204 CCL22 Human bis(2-ethylhexyl) phthalate increases expression ISO Ccl22 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CCL22 mRNA CTD PMID:35550907 CCL22 Human bisphenol A affects expression ISO Ccl22 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CCL22 mRNA CTD PMID:25181051 CCL22 Human bisphenol A increases expression ISO Ccl22 (Mus musculus) 6480464 bisphenol A results in increased expression of CCL22 mRNA CTD PMID:38701888 CCL22 Human buta-1,3-diene decreases expression ISO Ccl22 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of CCL22 mRNA CTD PMID:29038090 CCL22 Human C60 fullerene increases expression ISO Ccl22 (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of CCL22 mRNA CTD PMID:20471445 CCL22 Human cannabidiol multiple interactions ISO Ccl22 (Mus musculus) 6480464 [lipopolysaccharide and E coli O55-B5 co-treated with Cannabidiol] results in decreased expression of CCL22 mRNA CTD PMID:30742662 CCL22 Human cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [TNF protein results in increased expression of CCL22 mRNA] CTD PMID:31250491 CCL22 Human capsaicin multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] more ... CTD PMID:22150557 CCL22 Human capsaicin increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Capsaicin results in increased expression of CCL22 protein CTD PMID:22150557 CCL22 Human carbon nanotube increases expression ISO Ccl22 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:21135415 and PMID:25554681 CCL22 Human carbon nanotube increases secretion ISO Ccl22 (Mus musculus) 6480464 Nanotubes and Carbon results in increased secretion of CCL22 protein CTD PMID:19371758 CCL22 Human carbon nanotube increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Nanotubes and Carbon results in increased expression of CCL22 mRNA CTD PMID:24911292 CCL22 Human ceric oxide increases expression ISO Ccl22 (Rattus norvegicus) 6480464 ceric oxide results in increased expression of CCL22 mRNA CTD PMID:29463257 CCL22 Human crocidolite asbestos increases expression ISO Ccl22 (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of CCL22 protein CTD PMID:21135415 CCL22 Human Cuprizon decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of CCL22 mRNA CTD PMID:26577399 CCL22 Human decabromodiphenyl ether decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of CCL22 mRNA CTD PMID:23914054 CCL22 Human decabromodiphenyl ether increases expression ISO Ccl22 (Mus musculus) 6480464 decabromobiphenyl ether results in increased expression of CCL22 protein CTD PMID:22972382 CCL22 Human deoxynivalenol increases expression ISO Ccl22 (Mus musculus) 6480464 deoxynivalenol results in increased expression of CCL22 mRNA CTD PMID:22968694 CCL22 Human diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL22 mRNA] CTD PMID:19350554 and PMID:19828696 CCL22 Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CCL22 mRNA CTD PMID:19128835 and PMID:19350554 CCL22 Human dibutyl phthalate multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of CCL22 protein] and Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of CCL22 protein] CTD PMID:35378083 CCL22 Human dibutyl phthalate decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of CCL22 protein CTD PMID:35378083 CCL22 Human dichloroacetic acid increases expression ISO Ccl22 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of CCL22 mRNA CTD PMID:28962523 CCL22 Human dichromium trioxide increases secretion EXP 6480464 chromic oxide analog results in increased secretion of CCL22 protein CTD PMID:24885771 CCL22 Human diisononyl phthalate increases expression ISO Ccl22 (Mus musculus) 6480464 diisononyl phthalate results in increased expression of CCL22 protein CTD PMID:20064775 CCL22 Human dimethylarsinic acid multiple interactions ISO Ccl22 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA CTD PMID:34876320 CCL22 Human dopamine decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Dopamine results in decreased expression of CCL22 mRNA CTD PMID:25818600 CCL22 Human ethanol increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Ethanol results in increased expression of CCL22 mRNA CTD PMID:31078653 CCL22 Human ethyl methanesulfonate decreases expression EXP 6480464 Ethyl Methanesulfonate results in decreased expression of CCL22 mRNA CTD PMID:23649840 CCL22 Human ferric oxide increases secretion EXP 6480464 ferric oxide results in increased secretion of CCL22 protein CTD PMID:24885771 CCL22 Human Fexofenadine hydrochloride decreases expression EXP 6480464 fexofenadine results in decreased expression of CCL22 mRNA and fexofenadine results in decreased expression of CCL22 protein CTD PMID:21109747 CCL22 Human flavonoids increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Flavonoids results in increased expression of CCL22 mRNA CTD PMID:18035473 CCL22 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of CCL22 mRNA CTD PMID:23649840 CCL22 Human fragrance increases expression EXP 6480464 Perfume results in increased expression of CCL22 mRNA CTD PMID:24768652 CCL22 Human gentamycin decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CCL22 mRNA CTD PMID:22061828 CCL22 Human graphite increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Graphite results in increased expression of CCL22 mRNA CTD PMID:29933104 CCL22 Human hydralazine multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA CTD PMID:17183730 CCL22 Human inulin multiple interactions ISO Ccl22 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CCL22 mRNA CTD PMID:36331819 CCL22 Human lipopolysaccharide increases secretion EXP 6480464 Lipopolysaccharides results in increased secretion of CCL22 protein CTD PMID:32800949 CCL22 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CCL22 mRNA CTD PMID:35811015 CCL22 Human lipopolysaccharide increases expression ISO Ccl22 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of CCL22 mRNA CTD PMID:15665042 and PMID:26582142 CCL22 Human lipopolysaccharide multiple interactions ISO Ccl22 (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL22 mRNA] CTD PMID:26582142 CCL22 Human lipopolysaccharide multiple interactions EXP 6480464 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL22 protein] more ... CTD PMID:16366002 more ... CCL22 Human methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of CCL22 mRNA CTD PMID:23649840 CCL22 Human methylarsonic acid multiple interactions ISO Ccl22 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA CTD PMID:34876320 CCL22 Human mycophenolic acid increases expression ISO Ccl22 (Mus musculus) 6480464 Mycophenolic Acid results in increased expression of CCL22 mRNA CTD PMID:19818335 CCL22 Human N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression EXP 6480464 N more ... CTD PMID:19013360 CCL22 Human N,N-diethyl-m-toluamide multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of CCL22 gene CTD PMID:33148267 CCL22 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CCL22 mRNA] CTD PMID:19350554 CCL22 Human N-nitrosodimethylamine increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CCL22 protein CTD PMID:17719030 CCL22 Human naproxen multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] and Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] CTD PMID:22150557 CCL22 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of CCL22 mRNA CTD PMID:24768652 and PMID:25583101 CCL22 Human nickel dichloride increases secretion EXP 6480464 nickel chloride results in increased secretion of CCL22 protein CTD PMID:18437699 CCL22 Human nickel dichloride affects expression ISO Ccl22 (Mus musculus) 6480464 nickel chloride affects the expression of CCL22 mRNA CTD PMID:24670797 CCL22 Human nickel sulfate increases expression ISO Ccl22 (Mus musculus) 6480464 nickel sulfate results in increased expression of CCL22 mRNA CTD PMID:16166746 CCL22 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of CCL22 mRNA CTD PMID:12060402 CCL22 Human nickel sulfate affects expression EXP 6480464 nickel sulfate affects the expression of CCL22 mRNA CTD PMID:18202158 CCL22 Human nifuroxazide multiple interactions EXP 6480464 nifuroxazide inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CCL22 mRNA] CTD PMID:28949055 CCL22 Human ozone multiple interactions ISO Ccl22 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCL22 mRNA more ... CTD PMID:25658374 more ... CCL22 Human ozone increases expression ISO Ccl22 (Mus musculus) 6480464 Ozone results in increased expression of CCL22 mRNA CTD PMID:26342085 CCL22 Human ozone increases expression EXP 6480464 Ozone results in increased expression of CCL22 mRNA CTD PMID:31476115 CCL22 Human ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCL22 mRNA and Aripiprazole inhibits the reaction [Ozone results in increased expression of CCL22 mRNA] CTD PMID:26035830 and PMID:31476115 CCL22 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Ccl22 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CCL22 mRNA CTD PMID:36331819 CCL22 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CCL22 mRNA CTD PMID:36326898 CCL22 Human permethrin multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of CCL22 gene CTD PMID:33148267 CCL22 Human pevonedistat affects expression EXP 6480464 pevonedistat affects the expression of CCL22 mRNA CTD PMID:24634471 CCL22 Human prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of CCL22 mRNA CTD PMID:16303787 CCL22 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of CCL22 mRNA CTD PMID:30851411 CCL22 Human resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CCL22 mRNA CTD PMID:23224687 CCL22 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCL22 mRNA CTD PMID:23557933 CCL22 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 CCL22 Human silicon dioxide increases expression ISO Ccl22 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CCL22 mRNA CTD PMID:23221170 and PMID:29341224 CCL22 Human sodium arsenate multiple interactions ISO Ccl22 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA CTD PMID:34876320 CCL22 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CCL22 mRNA CTD PMID:34032870 CCL22 Human sodium arsenite multiple interactions ISO Ccl22 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCL22 mRNA CTD PMID:34876320 CCL22 Human sodium arsenite increases expression ISO Ccl22 (Mus musculus) 6480464 sodium arsenite results in increased expression of CCL22 mRNA CTD PMID:37682722 CCL22 Human sodium fluoride increases expression ISO Ccl22 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of CCL22 mRNA CTD PMID:21340527 CCL22 Human sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCL22 mRNA CTD PMID:36139627 CCL22 Human sterigmatocystin increases expression ISO Ccl22 (Mus musculus) 6480464 Sterigmatocystin results in increased expression of CCL22 mRNA CTD PMID:19818335 CCL22 Human succimer multiple interactions ISO Ccl22 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL22 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL22 mRNA CTD PMID:21641980 and PMID:26378955 CCL22 Human sumatriptan multiple interactions ISO Ccl22 (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] and Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CCL22 protein] CTD PMID:22150557 CCL22 Human thioacetamide increases expression ISO Ccl22 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CCL22 mRNA CTD PMID:34492290 CCL22 Human titanium dioxide increases expression ISO Ccl22 (Mus musculus) 6480464 titanium dioxide results in increased expression of CCL22 mRNA CTD PMID:21259345 CCL22 Human titanium dioxide increases expression ISO Ccl22 (Rattus norvegicus) 6480464 titanium dioxide results in increased expression of CCL22 mRNA CTD PMID:30012374 CCL22 Human TMC-120A increases expression ISO Ccl22 (Mus musculus) 6480464 TMC 120A results in increased expression of CCL22 mRNA CTD PMID:19818335 CCL22 Human toluene 2,4-diisocyanate increases expression ISO Ccl22 (Mus musculus) 6480464 Toluene 2 and 4-Diisocyanate results in increased expression of CCL22 mRNA CTD PMID:21404309 CCL22 Human trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCL22 mRNA CTD PMID:36139627 CCL22 Human triptonide increases expression ISO Ccl22 (Mus musculus) 6480464 triptonide results in increased expression of CCL22 mRNA CTD PMID:33045310 CCL22 Human trovafloxacin increases expression ISO Ccl22 (Mus musculus) 6480464 trovafloxacin results in increased expression of CCL22 mRNA CTD PMID:35537566 CCL22 Human valproic acid multiple interactions EXP 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA CTD PMID:17183730 CCL22 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CCL22 mRNA CTD PMID:37505509 CCL22 Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of CCL22 mRNA CTD PMID:23649840 CCL22 Human zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of CCL22 mRNA CTD PMID:27757495 CCL22 Human zinc oxide decreases expression ISO Ccl22 (Rattus norvegicus) 6480464 Zinc Oxide results in decreased expression of CCL22 protein CTD PMID:33205376